Authors:
- Includes supplementary material: sn.pub/extras
Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 163 / 2)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (22 chapters)
-
Front Matter
-
Tissues
-
Front Matter
-
Brain/Nervous System
-
-
Inhibition of the Renin-Angiotensin System
-
Front Matter
-
About this book
Nearly thirty years ago, in 1974, the volume on Angiotensin edited by Irvine H.Page and F. Merlin Bumpus expanded the Handbook of Experimental Pharmacology. Even after two decades the multiplicity of its actions appears not to have been fully discovered. To call attention to its many functions is one of the purposes of this book. This new edition of the volume on Angiotensin attempts to provide an updated account of the knowledge and findings accumulated since the complexity of angiotensin was so accurately recognized.
Authors and Affiliations
-
Center for Cardiovascular Research (CCR) Institut für Pharmakologie und Toxikologie, Charité Campus Mitte Charité — Universitätsmedizin Berlin, Berlin, Germany
Thomas Unger
-
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval, Frankfurt/Main, Germany
Bernward A. Schölkens
Bibliographic Information
Book Title: Angiotensin Vol. II
Authors: Thomas Unger, Bernward A. Schölkens
Series Title: Handbook of Experimental Pharmacology
DOI: https://doi.org/10.1007/978-3-642-18497-0
Publisher: Springer Berlin, Heidelberg
-
eBook Packages: Springer Book Archive
Copyright Information: Springer-Verlag Berlin Heidelberg 2004
Hardcover ISBN: 978-3-540-40641-9Published: 31 March 2004
Softcover ISBN: 978-3-642-62133-8Published: 03 October 2013
eBook ISBN: 978-3-642-18497-0Published: 02 February 2012
Series ISSN: 0171-2004
Series E-ISSN: 1865-0325
Edition Number: 1
Number of Pages: XIV, 603
Topics: Pharmacology/Toxicology, Medical Biochemistry, Neurosciences, Medical Microbiology